Comments
Loading...

Poolbeg Pharma Analyst Ratings

POLBFOTCPK
Logo brought to you by Benzinga Data

Poolbeg Pharma Analyst Ratings and Price Targets | OTC:POLBF | Benzinga

Poolbeg Pharma Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Poolbeg Pharma Corp from these most-recent analyst ratings.

Analyst Ratings for Poolbeg Pharma

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Poolbeg Pharma (POLBF) stock?

A

There is no price target for Poolbeg Pharma

Q

What is the most recent analyst rating for Poolbeg Pharma (POLBF)?

A

There is no analyst for Poolbeg Pharma

Q

When was the last upgrade for Poolbeg Pharma (POLBF)?

A

There is no last upgrade for Poolbeg Pharma

Q

When was the last downgrade for Poolbeg Pharma (POLBF)?

A

There is no last downgrade for Poolbeg Pharma.

Q

When is the next analyst rating going to be posted or updated for Poolbeg Pharma (POLBF)?

A

There is no next analyst rating for Poolbeg Pharma.

Q

Is the Analyst Rating Poolbeg Pharma (POLBF) correct?

A

There is no next analyst rating for Poolbeg Pharma.

Browse analyst ratings and price targets on all stocks.